ID

24071

Description

Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00506662

Link

https://clinicaltrials.gov/show/NCT00506662

Keywords

  1. 7/24/17 7/24/17 -
Uploaded on

July 24, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes NCT00506662

Eligibility Diabetes NCT00506662

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00506662
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes
Description

Diabetes Mellitus, Non-Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011860
insulin naive
Description

Insulin naive

Data type

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C0919936
treatment with oral anti-diabetic drugs (oads) for at least 3 months and not achieving therapeutic targets
Description

Antidiabetics Oral | Target Therapeutic Unavailable

Data type

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [2,1]
C1521840
UMLS CUI [2,2]
C0302350
UMLS CUI [2,3]
C0686905
hba1c between 8% - 10.5%
Description

Glycosylated hemoglobin A

Data type

boolean

Alias
UMLS CUI [1]
C0019018
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
secondary diabetes, mody (maturity onset diabetes of the young)
Description

Secondary diabetes mellitus | Maturity onset diabetes mellitus in young

Data type

boolean

Alias
UMLS CUI [1]
C0271640
UMLS CUI [2]
C0342276
previous treatment with insulin (except for short-term treatment with insulin for intercurrent illness as judged by the investigator)
Description

Insulin | Exclusion Insulin short-term Comorbidity

Data type

boolean

Alias
UMLS CUI [1]
C0021641
UMLS CUI [2,1]
C2828389
UMLS CUI [2,2]
C0021641
UMLS CUI [2,3]
C0443303
UMLS CUI [2,4]
C0009488
proliferative retinopathy, maculopathy requiring treatment,
Description

Proliferative retinopathy | Maculopathy Requirement Therapeutic procedure

Data type

boolean

Alias
UMLS CUI [1]
C0339467
UMLS CUI [2,1]
C0730362
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0087111
hypoglycaemia unawareness as judged by the investigator, recurrent major hypoglycaemia
Description

Loss of hypoglycemic warning | Recurrent severe hypoglycemia

Data type

boolean

Alias
UMLS CUI [1]
C0342317
UMLS CUI [2]
C0342316
end stage liver disease (increased liver enzymes 4 fold), end stage renal disease assessed by mdrd (modification of diet in renal disease) less than 30 ml/min or dialysed patient, acute heart failure, any acute cardiovascular event or cerebrovascular event less than 6 months
Description

End Stage Liver Disease | Elevated liver enzymes | Chronic Kidney Failure Modification of diet in renal disease formula | Dialysis | Heart failure | Cardiovascular event | Event Cerebrovascular

Data type

boolean

Alias
UMLS CUI [1]
C0745744
UMLS CUI [2]
C0235996
UMLS CUI [3,1]
C0022661
UMLS CUI [3,2]
C3839656
UMLS CUI [4]
C0011946
UMLS CUI [5]
C0018801
UMLS CUI [6]
C1320716
UMLS CUI [7,1]
C0441471
UMLS CUI [7,2]
C1880018
acute disease with poor prognosis
Description

Disease Prognosis bad

Data type

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0278252
history of alcoholism, drug abuse, or psychiatric disease or personality disorders likely to invalidate voluntary consent or to prevent good compliance with the trial protocol
Description

Alcoholic Intoxication, Chronic | Drug abuse | Mental disorders | Personality Disorders | Condition Interferes with Informed Consent | Condition Preventing Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1]
C0001973
UMLS CUI [2]
C0013146
UMLS CUI [3]
C0004936
UMLS CUI [4]
C0031212
UMLS CUI [5,1]
C0348080
UMLS CUI [5,2]
C0521102
UMLS CUI [5,3]
C0021430
UMLS CUI [6,1]
C0348080
UMLS CUI [6,2]
C1292733
UMLS CUI [6,3]
C0525058
mental incapacity, unwillingness or language barrier precluding adequate understanding or co-operation (patients having a score of less than 15 in a previous mmse (mini-mental state examination) in the last six months) and any conditions as judged by the investigator
Description

Mental handicap Excludes Comprehension | Comprehension Unwilling | Language Barriers Exclude Comprehension | Mental handicap Excludes Compliance behavior | Compliance behavior Unwilling | Language Barriers Exclude Compliance behavior | Mini-mental state examination

Data type

boolean

Alias
UMLS CUI [1,1]
C1306341
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0162340
UMLS CUI [2,1]
C0162340
UMLS CUI [2,2]
C0558080
UMLS CUI [3,1]
C0237167
UMLS CUI [3,2]
C0332196
UMLS CUI [3,3]
C0162340
UMLS CUI [4,1]
C1306341
UMLS CUI [4,2]
C0332196
UMLS CUI [4,3]
C1321605
UMLS CUI [5,1]
C1321605
UMLS CUI [5,2]
C0558080
UMLS CUI [6,1]
C0237167
UMLS CUI [6,2]
C0332196
UMLS CUI [6,3]
C1321605
UMLS CUI [7]
C0451306
legal incapacity or limited legal capacity (patients under guardianship or curatorship)
Description

Disability Legal | Limited function/disability Legal | Patient guardianship

Data type

boolean

Alias
UMLS CUI [1,1]
C0231170
UMLS CUI [1,2]
C1301860
UMLS CUI [2,1]
C0497533
UMLS CUI [2,2]
C1301860
UMLS CUI [3,1]
C0030705
UMLS CUI [3,2]
C0870627
concomitant medication for alzheimers treatment (memantine, anticholinesterasique treatment)
Description

Pharmaceutical Preparations Alzheimer's Disease | Memantine | Cholinesterase Inhibitors

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0002395
UMLS CUI [2]
C0025242
UMLS CUI [3]
C0008425
participation in another clinical trial less than one month before inclusion in this trial
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
illness requiring repeated hospitalisation
Description

Illness Requirement Hospitalization Repeated

Data type

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0019993
UMLS CUI [1,4]
C0205341
known or suspected allergy to the insulin or any compositional component
Description

Insulin allergy | Hypersensitivity Insulin Component | Insulin allergy Suspected | Hypersensitivity Insulin Component Suspected

Data type

boolean

Alias
UMLS CUI [1]
C0571622
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0021641
UMLS CUI [2,3]
C1705248
UMLS CUI [3,1]
C0571622
UMLS CUI [3,2]
C0750491
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0021641
UMLS CUI [4,3]
C1705248
UMLS CUI [4,4]
C0750491
anticipated change or new use in concomitant medication known to interfere with glucose metabolism, such as systemic corticotherapy more than 5 mg/day (prednisone)
Description

Pharmaceutical Preparation Interferes with Glucose metabolism | Systemic Corticosteroid Therapy | Prednisone

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0596620
UMLS CUI [2]
C4053960
UMLS CUI [3]
C0032952
any other condition that the investigator feels would interfere with trial participation or evaluation of results
Description

Condition Interferes with Study Subject Participation Status | Condition Interferes with Evaluation Research results

Data type

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C2348568
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C1261322
UMLS CUI [2,4]
C0683954
terminal illness
Description

Terminal illness

Data type

boolean

Alias
UMLS CUI [1]
C0679247

Similar models

Eligibility Diabetes NCT00506662

  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT00506662
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Insulin naive
Item
insulin naive
boolean
C0021641 (UMLS CUI [1,1])
C0919936 (UMLS CUI [1,2])
Antidiabetics Oral | Target Therapeutic Unavailable
Item
treatment with oral anti-diabetic drugs (oads) for at least 3 months and not achieving therapeutic targets
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1521840 (UMLS CUI [2,1])
C0302350 (UMLS CUI [2,2])
C0686905 (UMLS CUI [2,3])
Glycosylated hemoglobin A
Item
hba1c between 8% - 10.5%
boolean
C0019018 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Secondary diabetes mellitus | Maturity onset diabetes mellitus in young
Item
secondary diabetes, mody (maturity onset diabetes of the young)
boolean
C0271640 (UMLS CUI [1])
C0342276 (UMLS CUI [2])
Insulin | Exclusion Insulin short-term Comorbidity
Item
previous treatment with insulin (except for short-term treatment with insulin for intercurrent illness as judged by the investigator)
boolean
C0021641 (UMLS CUI [1])
C2828389 (UMLS CUI [2,1])
C0021641 (UMLS CUI [2,2])
C0443303 (UMLS CUI [2,3])
C0009488 (UMLS CUI [2,4])
Proliferative retinopathy | Maculopathy Requirement Therapeutic procedure
Item
proliferative retinopathy, maculopathy requiring treatment,
boolean
C0339467 (UMLS CUI [1])
C0730362 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
Loss of hypoglycemic warning | Recurrent severe hypoglycemia
Item
hypoglycaemia unawareness as judged by the investigator, recurrent major hypoglycaemia
boolean
C0342317 (UMLS CUI [1])
C0342316 (UMLS CUI [2])
End Stage Liver Disease | Elevated liver enzymes | Chronic Kidney Failure Modification of diet in renal disease formula | Dialysis | Heart failure | Cardiovascular event | Event Cerebrovascular
Item
end stage liver disease (increased liver enzymes 4 fold), end stage renal disease assessed by mdrd (modification of diet in renal disease) less than 30 ml/min or dialysed patient, acute heart failure, any acute cardiovascular event or cerebrovascular event less than 6 months
boolean
C0745744 (UMLS CUI [1])
C0235996 (UMLS CUI [2])
C0022661 (UMLS CUI [3,1])
C3839656 (UMLS CUI [3,2])
C0011946 (UMLS CUI [4])
C0018801 (UMLS CUI [5])
C1320716 (UMLS CUI [6])
C0441471 (UMLS CUI [7,1])
C1880018 (UMLS CUI [7,2])
Disease Prognosis bad
Item
acute disease with poor prognosis
boolean
C0012634 (UMLS CUI [1,1])
C0278252 (UMLS CUI [1,2])
Alcoholic Intoxication, Chronic | Drug abuse | Mental disorders | Personality Disorders | Condition Interferes with Informed Consent | Condition Preventing Protocol Compliance
Item
history of alcoholism, drug abuse, or psychiatric disease or personality disorders likely to invalidate voluntary consent or to prevent good compliance with the trial protocol
boolean
C0001973 (UMLS CUI [1])
C0013146 (UMLS CUI [2])
C0004936 (UMLS CUI [3])
C0031212 (UMLS CUI [4])
C0348080 (UMLS CUI [5,1])
C0521102 (UMLS CUI [5,2])
C0021430 (UMLS CUI [5,3])
C0348080 (UMLS CUI [6,1])
C1292733 (UMLS CUI [6,2])
C0525058 (UMLS CUI [6,3])
Mental handicap Excludes Comprehension | Comprehension Unwilling | Language Barriers Exclude Comprehension | Mental handicap Excludes Compliance behavior | Compliance behavior Unwilling | Language Barriers Exclude Compliance behavior | Mini-mental state examination
Item
mental incapacity, unwillingness or language barrier precluding adequate understanding or co-operation (patients having a score of less than 15 in a previous mmse (mini-mental state examination) in the last six months) and any conditions as judged by the investigator
boolean
C1306341 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
C0162340 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
C0237167 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
C0162340 (UMLS CUI [3,3])
C1306341 (UMLS CUI [4,1])
C0332196 (UMLS CUI [4,2])
C1321605 (UMLS CUI [4,3])
C1321605 (UMLS CUI [5,1])
C0558080 (UMLS CUI [5,2])
C0237167 (UMLS CUI [6,1])
C0332196 (UMLS CUI [6,2])
C1321605 (UMLS CUI [6,3])
C0451306 (UMLS CUI [7])
Disability Legal | Limited function/disability Legal | Patient guardianship
Item
legal incapacity or limited legal capacity (patients under guardianship or curatorship)
boolean
C0231170 (UMLS CUI [1,1])
C1301860 (UMLS CUI [1,2])
C0497533 (UMLS CUI [2,1])
C1301860 (UMLS CUI [2,2])
C0030705 (UMLS CUI [3,1])
C0870627 (UMLS CUI [3,2])
Pharmaceutical Preparations Alzheimer's Disease | Memantine | Cholinesterase Inhibitors
Item
concomitant medication for alzheimers treatment (memantine, anticholinesterasique treatment)
boolean
C0013227 (UMLS CUI [1,1])
C0002395 (UMLS CUI [1,2])
C0025242 (UMLS CUI [2])
C0008425 (UMLS CUI [3])
Study Subject Participation Status
Item
participation in another clinical trial less than one month before inclusion in this trial
boolean
C2348568 (UMLS CUI [1])
Illness Requirement Hospitalization Repeated
Item
illness requiring repeated hospitalisation
boolean
C0221423 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0019993 (UMLS CUI [1,3])
C0205341 (UMLS CUI [1,4])
Insulin allergy | Hypersensitivity Insulin Component | Insulin allergy Suspected | Hypersensitivity Insulin Component Suspected
Item
known or suspected allergy to the insulin or any compositional component
boolean
C0571622 (UMLS CUI [1])
C0020517 (UMLS CUI [2,1])
C0021641 (UMLS CUI [2,2])
C1705248 (UMLS CUI [2,3])
C0571622 (UMLS CUI [3,1])
C0750491 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0021641 (UMLS CUI [4,2])
C1705248 (UMLS CUI [4,3])
C0750491 (UMLS CUI [4,4])
Pharmaceutical Preparation Interferes with Glucose metabolism | Systemic Corticosteroid Therapy | Prednisone
Item
anticipated change or new use in concomitant medication known to interfere with glucose metabolism, such as systemic corticotherapy more than 5 mg/day (prednisone)
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
C4053960 (UMLS CUI [2])
C0032952 (UMLS CUI [3])
Condition Interferes with Study Subject Participation Status | Condition Interferes with Evaluation Research results
Item
any other condition that the investigator feels would interfere with trial participation or evaluation of results
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C1261322 (UMLS CUI [2,3])
C0683954 (UMLS CUI [2,4])
Terminal illness
Item
terminal illness
boolean
C0679247 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial